| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 850429-62-8 | 2-(boc-氨基)噻唑-4-羧酸甲酯 | methyl 2-boc-aminothiazole-4-carboxylate | C10H14N2O4S | 258.29 | 156-160°C | |
| 850429-63-9 | | 6-methylsulfonyloxindole | | | | |
| 850429-64-0 | 4,5-二氟吲哚酮 | 4,5-difluoroindolin-2-one | C8H5F2NO | 169.13 | | 294.7°C at 760 mmHg |
| 850429-67-3 | | n-benzyl-3-bromo-4-methylbenzenesulfonamide | C14H14BrNO2S | 340.24 | | |
| 850429-68-4 | | n-butyl 3-bromo-4-methylbenzenesulfonamide | | | | |
| 850429-70-8 | | n-tert-butyl 3-bromo-4-methylbenzenesulfonamide | | | | |
| 850429-73-1 | | 1-((3-bromo-4-methylphenyl)sulfonyl)piperidine | C12H16BrNO2S | 318.2 | | |
| 850429-74-2 | | 4-((3-bromo-4-methylphenyl)sulfonyl)morpholine | C11H14BrNO3S | 320.2 | | |
| 850429-75-3 | 1-(3-溴-4-甲基苯磺酰基)吡咯烷 | 1-(3-Bromo-4-methylphenylsulfonyl)pyrrolidine | C11H14BrNO2S | 304.2 | | |
| 850444-36-9 | (sp)-1-[(s)-α-(二甲氨基)-2-(二苯基膦)苄基]-2-二苯基膦二茂铁 | taniaphos sl-t001-2 | C43H39FeNP2 | 687.57 | | |
| 850445-47-5 | 2-(Trifluoromethyl)imidazo[1,2-a]pyrazin-8-ol | | C7H4F3N3O | 203.12 | | |
| 850446-24-1 | | 2',5'-bis(decyloxy)-[1,1':4',1''-terphenyl]-4,4''-dicarbalde | C40H54O4 | 598.854 | | |
| 850449-93-3 | 2-(-氨基-2-甲基苯基)乙酸甲酯 | methyl 2-(5-amino-2-methylphenyl)acetate | C10H13NO2 | 179.22 | | 298.288°C at 760 mmHg |
| 85045-54-1 | | alpha-(1-hydroxy-1-methylethyl)-1'-biphenyl)-4-acetic aci (+)-( | | | | |
| 85045-55-2 | | alpha-(1-hydroxy-1-methylethyl)-1'-biphenyl)-4-acetic aci (-)-( | | | | |
| 85045-58-5 | | alpha-(1-ethyl-1-hydroxypropyl)-1'-biphenyl)-4-acetic aci (+)-( | | | | |
| 85045-59-6 | | alpha-(1-ethyl-1-hydroxypropyl)-1'-biphenyl)-4-acetic aci (-)-( | | | | |
| 85045-62-1 | | 1'-biphenyl)-4-acetic acid, alpha-(1-hydroxy-1-phenylethyl)-, (r*,s*)-(+)-( | | | | |
| 85045-63-2 | | 1'-biphenyl)-4-acetic acid, alpha-(1-hydroxy-1-phenylethyl)-, (r*,s*)-(-)-( | | | | |
| 85045-65-4 | | 1'-biphenyl)-4-acetic acid, alpha-(1-hydroxy-1-phenylethyl)-, (r*,r*)-(+-)-( | | | | |
| 85045-68-7 | | alpha-(1-hydroxycyclohexyl)-1'-biphenyl)-4-acetic aci (+)-( | | | | |
| 85045-69-8 | | alpha-(1-hydroxycyclohexyl)-1'-biphenyl)-4-acetic aci (-)-( | | | | |
| 85045-72-3 | | alpha-(1-hydroxy-4-methylcyclohexyl)-1'-biphenyl)-4-acetic aci cis-(+)-( | | | | |
| 85045-73-4 | | alpha-(1-hydroxy-4-methylcyclohexyl)-1'-biphenyl)-4-acetic aci cis-(-)-( | | | | |
| 85045-76-7 | | 1'-biphenyl)-4-acetic acid, alpha-(1-hydroxy-4-methylcyclohexyl)-( trans-(+) | | | | |
| 85045-77-8 | | 1'-biphenyl)-4-acetic acid, alpha-(1-hydroxy-4-methylcyclohexyl)-( trans-(-) | | | | |
| 85045-80-3 | | alpha-(1-hydroxycyclopentyl)-1'-biphenyl)-4-acetic aci (+)-( | | | | |
| 85045-81-4 | | alpha-(1-hydroxycyclopentyl)-1'-biphenyl)-4-acetic aci (-)-( | | | | |
| 850462-64-5 | 5-氟-2-甲基-3-硝基苯甲酸 | 5-fluoro-2-methyl-3-nitrobenzoic acid | C8H6FNO4 | 199.14 | | |
| 850462-65-6 | 2-(溴甲基)-5-氟-3-硝基苯甲酸甲酯 | methyl 2-(bromomethyl)-5-fluoro-3-nitrobenzoate | C9H7BrFNO4 | 292.0586 | | |
| 850467-66-2 | TAO Kinase inhibitor 1 | | C25H24N2O2 | 384.47 | | |
| 850467-77-5 | N-(2-氧代-2-((1,2,3,4-四氢萘-1-基)氨基)乙基)-4-苯氧基苯甲酰胺 | N-(2-Oxo-2-((1,2,3,4-tetrahydronaphthalen-1-yl)amino)ethyl)-4-phenoxybenzamide | C25H24N2O3 | 400.47 | | 665.5±55.0 °C(Predicted) |
| 850468-97-2 | (S)-3-(1-羟基-4-甲基戊烷-2-基)-1-三甲基-4,5-二氢-1H-咪唑-3-六氟磷酸铵(V) | (S)-3-(1-Hydroxy-4-methylpentan-2-yl)-1-mesityl-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V) | C18H29F6N2OP | 434.40 | | |
| 850468-98-3 | (S)-1-(1-羟基-4-甲基戊-2-基)-3-均三甲苯基-4,5-二氢-1H-咪唑-3-鎓六氟磷酸盐(V) | (S)-1-(1-Hydroxy-4-methylpentan-2-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V) | C18H29F6N2OP | 434.4 | | |
| 850469-00-0 | (S)-1-(1-羟基-3-甲基丁-2-基)-3-均三甲苯基-4,5-二氢-1H-咪唑-3-鎓六氟磷酸盐 | (S)-1-(1-Hydroxy-3-methylbutan-2-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V) | C17H27N2O+.F6P- | 420.3730 | | |
| 850469-04-4 | (S)-1-(1-羟基-3,3-二甲基丁烷-2-基)-3-均三甲苯基-4,5-二氢-1H-咪唑-3-鎓六氟磷酸盐 | (S)-1-(1-Hydroxy-3,3-dimethylbutan-2-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V) | C18H29N2O+.F6P- | 434.4000 | | |
| 850469-07-7 | (S)-1-(2,6-二异丙基苯基)-3-(1-羟基-3-甲基丁烷-2-基)-4,5-二氢-1H-咪唑-3-六氟磷酸铵(V) | (S)-1-(2,6-Diisopropylphenyl)-3-(1-hydroxy-3-methylbutan-2-yl)-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V) | C20H33F6N2OP | 462.45 | | |
| 850469-08-8 | (S)-3-(2,6-二异丙基苯基)-1-(1-羟基-3-甲基丁-2-基)-4,5-二氢-1H-咪唑-3-鎓六氟磷酸盐(V) | (S)-3-(2,6-Diisopropylphenyl)-1-(1-hydroxy-3-methylbutan-2-yl)-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V) | C20H33F6N2OP | 462.45 | | |
| 85047-08-1 | | ethanolamine (1,1,2,2-d4, 98%) | | | | |
| 85048-88-0 | | 5-amino-5-hydroxy-2,4,6(1h,3h,5h)pyrimidinetrione | | | | |
| 85049-29-2 | | amines, di-c14-18-alkylmethyl, [29h,31h-phthalocyaninedisulfonato(4-)-n29,n39,n | | | | |
| 85049-30-5 | 膨润土钠 | Bentonite, sodium | Al2H2Na2O13Si4 | 422.293 | | |
| 85049-34-9 | | fatty acids, c16-18 and c18-unsatd., esters with propylene glycol | | | | |
| 85049-37-2 | (C16-18、C18不饱和)脂肪酸-2-乙基己酯 | Fatty acids, C16-18 and C18-unsatd., 2-ethylhexyl esters | | | | |
| 85049-41-8 | 支链-C8-10-脂肪酸钙盐 | Fatty acids, C8-10-branched, calcium salts | | | | |
| 85049-44-1 | C8-10-脂肪酸与二丁基胺的化合物 | Fatty acids, C8-10-compds. with N-butyl-1-butanamine | | | | |
| 85049-57-6 | 硫化菜油与油酸甲酯的化合物 | Rape oil, mixed with Me oleate, sulfurized | | | | |
| 85049-62-3 | 二[2-[[[5-[(2-氯代-5-磺苯基)偶氮基]-2-羟苯基]亚甲基]氨基]苯甲酸基(3-)]铬酸基(3-)钾钠 | Chromate(3-), bis[2-[[[5-[(2-chloro-5-sulfophenyl)azo]-2-hydroxyphenyl] methylene] amino]benzoato(3-)]-, potassium sodium | | | | |
| 85049-63-4 | 二[3-[(4,5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基-5-硝基苯磺酸根合(3-)]铬酸(3-)乙醇胺钾盐 | Chromate(3-), bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)]-, ethanolamine potassium salts | | | | |
| 85049-64-5 | 二[3-[(4,5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基-5-硝基苯磺酸根合(3-)]铬酸(3-)钾盐 | Chromate(3-), bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)]-, potassium | | | | |
m.cnreagent.com